Investor Presentaiton slide image

Investor Presentaiton

24 Innovative R&D - Incubation & Early Stage Investments Incubation & Early Stage Investments: enrich the R&D pipeline to target cutting-edge technologies at an earlier stage Incubation Early-stage Investment Fosun Lead was founded in 2019, focusing on world- leading biotechnologies and information technologies. Including gene therapy platform GeCell, Al-assisting precision medicine for Oncology, personalized new antigen immunotherapy and others. Other projects includes portable MRI, handheld ultrasound device and Protein Sequencer Fusion is a platform under Fosun Pharma US in Boston and incubated Archimmune Therapeutics which has two immuno-oncology platforms: personalized cancer vaccine (ACNP) and Multi-specific immuno- nano therapy (MINP) Participated in overseas healthcare professional funds such as Pontifax Venture Capital, Berkeley Catalyst Fund I, LP Partners Innovation Fund II, LP for access to leading technologies globally with potential in-license and other collaboration opportunities Fosun Health Capital has completed financing as Fosun's first VC fund for innovative drugs. Project invested so far include Biomissile (bi-specific antibody) and Tianjin JuveStar (medical aesthetic)
View entire presentation